Jason Politi
Hoofd Techniek/Wetenschap/O&O bij VERVE THERAPEUTICS, INC.
Profiel
Jason Politi is currently the Chief Technical Operations Officer at Verve Therapeutics, Inc. Prior to his current position, he held the role of Senior Director-Clinical Manufacturing at Alexion Pharmaceuticals, Inc. and Senior Vice President-Technical Operations at Prevail Therapeutics, Inc. Mr. Politi completed his undergraduate degree at Massachusetts Institute of Technology and holds an MBA from Boston College.
Actieve functies van Jason Politi
| Bedrijven | Functie | Begin |
|---|---|---|
| VERVE THERAPEUTICS, INC. | Hoofd Techniek/Wetenschap/O&O | 01-02-2021 |
Eerdere bekende functies van Jason Politi
| Bedrijven | Functie | Einde |
|---|---|---|
| ALEXION PHARMACEUTICALS, INC. | Corporate Officer/Principal | - |
| PREVAIL THERAPEUTICS INC. | Hoofd Techniek/Wetenschap/O&O | - |
Opleiding van Jason Politi
| Massachusetts Institute of Technology | Undergraduate Degree |
| Boston College | Masters Business Admin |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| VERVE THERAPEUTICS, INC. | Health Technology |
| Bedrijven in privébezit | 2 |
|---|---|
Prevail Therapeutics, Inc.
 Prevail Therapeutics, Inc. BiotechnologyHealth Technology Prevail Therapeutics, Inc. develops therapeutics for neurodegenerative diseases. The firm engages in the research and development of novel biologic gene therapies to treat Parkinson's disease and other neurodegenerative diseases. The company was founded by Asa Abeliovich on July 6, 2017 and is headquartered in New York, NY. | Health Technology |
Alexion Pharmaceuticals, Inc.
 Alexion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Alexion Pharmaceuticals, Inc. engages in the business of serving patients and families affected by rare diseases and devastating conditions through the discovery, development, and commercialization of life-changing medicines. The firm also focuses on the development of haematology, nephrology, neurology, metabolic disorders, cardiology, and ophthalmology. The company was founded by Joseph A. Madri, David W. Keiser, Stephen P. Squinto, and Leonard Bell in January 1992 and is headquartered in Boston, MA. | Health Technology |
